Skip to content
Pharma Observatory a Scientist.com platform
  • Trial site

Trial site location from the registry's own city and country. GeoNames (geonames.org).

Clinical trial site

Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center in New York, New York, United States is listed as a site for 4,054 registered clinical trials, 1193 of them ongoing.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Registered trials 4,054
Ongoing 1,193

This page covers the site record Memorial Sloan Kettering Cancer Center in New York, New York, United States: the trials that list it by this name in ClinicalTrials.gov. The same place can be registered under other names, each with its own page and its own trials, and a count here is a number of registered trials, not of patients enrolled. The organization of the same name, Memorial Sloan Kettering Cancer Center, also sponsors trials.

Get the Memorial Sloan Kettering Cancer Center report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Trials by phase

Registered trials that list this site, by trial phase. 4,054 trials counted.

  • Phase 1 895 trials
  • Phase 1/2 418 trials
  • Phase 2 1,264 trials
  • Phase 2/3 46 trials
  • Phase 3 545 trials
  • Phase 4 13 trials
  • Not applicable 342 trials
  • Observational 505 trials
  • Expanded access 25 trials
  • Unknown 1 trial

Trials by status

The registry's own status summary: Ongoing, Completed, Terminated or Other.

  • Ongoing 1,200 trials
  • Completed 2,324 trials
  • Terminated 452 trials
  • Other 78 trials

Trials over time

Trials registered with a start date in each year, 1990 onward, most recent years first.

Trials over time, by phase

  • Phase 1
  • Phase 1/2
  • Phase 2
  • Phase 2/3
  • Phase 3
  • Phase 4
  • Not applicable
  • Observational
  • Other (Expanded access, Unknown)

Top of scale: 217

1990: 4 trials (Observational 1, Phase 2 3) 1991: 5 trials (Observational 2, Phase 2 1, Phase 1 2) 1992: 4 trials (Observational 1, Phase 3 1, Phase 2 2) 1993: 5 trials (Observational 2, Not applicable 1, Phase 3 2) 1994: 20 trials (Observational 1, Phase 3 7, Phase 2 8, Phase 1/2 3, Phase 1 1) 1995: 18 trials (Observational 3, Phase 3 1, Phase 2/3 1, Phase 2 8, Phase 1/2 3, Phase 1 2) 1996: 24 trials (Observational 1, Phase 3 12, Phase 2/3 1, Phase 2 7, Phase 1 3) 1997: 56 trials (Observational 6, Not applicable 2, Phase 3 10, Phase 2 20, Phase 1/2 5, Phase 1 13) 1998: 88 trials (Observational 6, Not applicable 2, Phase 3 14, Phase 2 37, Phase 1/2 4, Phase 1 25) 1999: 89 trials (Observational 8, Not applicable 5, Phase 3 17, Phase 2 35, Phase 1/2 2, Phase 1 22) 2000: 108 trials (Observational 10, Not applicable 4, Phase 3 13, Phase 2 49, Phase 1/2 4, Phase 1 28) 2001: 91 trials (Observational 5, Not applicable 7, Phase 3 9, Phase 2 47, Phase 1/2 7, Phase 1 16) 2002: 70 trials (Observational 6, Not applicable 6, Phase 3 9, Phase 2 27, Phase 1/2 5, Phase 1 17) 2003: 107 trials (Observational 16, Not applicable 10, Phase 3 17, Phase 2/3 1, Phase 2 42, Phase 1/2 5, Phase 1 16) 2004: 101 trials (Observational 25, Not applicable 13, Phase 3 12, Phase 2 29, Phase 1/2 3, Phase 1 19) 2005: 83 trials (Observational 21, Not applicable 7, Phase 3 10, Phase 2 19, Phase 1/2 8, Phase 1 18) 2006: 114 trials (Other 1, Observational 20, Not applicable 12, Phase 3 12, Phase 2 39, Phase 1/2 12, Phase 1 18) 2007: 123 trials (Other 1, Observational 22, Not applicable 11, Phase 3 12, Phase 2 50, Phase 1/2 6, Phase 1 21) 2008: 93 trials (Observational 22, Not applicable 7, Phase 3 12, Phase 2 33, Phase 1/2 6, Phase 1 13) 2009: 125 trials (Observational 22, Not applicable 10, Phase 3 23, Phase 2 47, Phase 1/2 7, Phase 1 16) 2010: 135 trials (Observational 19, Not applicable 18, Phase 4 1, Phase 3 17, Phase 2/3 1, Phase 2 46, Phase 1/2 10, Phase 1 23) 2011: 155 trials (Observational 30, Not applicable 13, Phase 3 16, Phase 2/3 1, Phase 2 50, Phase 1/2 11, Phase 1 34) 2012: 143 trials (Observational 18, Not applicable 17, Phase 3 15, Phase 2/3 1, Phase 2 51, Phase 1/2 15, Phase 1 26) 2013: 146 trials (Observational 18, Not applicable 20, Phase 3 13, Phase 2/3 1, Phase 2 44, Phase 1/2 16, Phase 1 34) 2014: 161 trials (Observational 22, Not applicable 20, Phase 3 15, Phase 2/3 3, Phase 2 43, Phase 1/2 19, Phase 1 39) 2015: 180 trials (Observational 31, Not applicable 28, Phase 4 1, Phase 3 18, Phase 2/3 2, Phase 2 45, Phase 1/2 23, Phase 1 32) 2016: 186 trials (Observational 26, Not applicable 22, Phase 4 1, Phase 3 21, Phase 2/3 6, Phase 2 37, Phase 1/2 21, Phase 1 52) 2017: 217 trials (Observational 26, Not applicable 14, Phase 4 3, Phase 3 32, Phase 2/3 2, Phase 2 70, Phase 1/2 25, Phase 1 45) 2018: 187 trials (Observational 15, Not applicable 13, Phase 3 22, Phase 2/3 3, Phase 2 63, Phase 1/2 21, Phase 1 50) 2019: 210 trials (Observational 21, Not applicable 17, Phase 4 1, Phase 3 25, Phase 2/3 3, Phase 2 49, Phase 1/2 36, Phase 1 58) 2020: 185 trials (Observational 19, Not applicable 12, Phase 4 1, Phase 3 28, Phase 2/3 2, Phase 2 59, Phase 1/2 27, Phase 1 37) 2021: 184 trials (Observational 14, Not applicable 13, Phase 3 25, Phase 2/3 4, Phase 2 48, Phase 1/2 19, Phase 1 61) 2022: 160 trials (Observational 12, Not applicable 10, Phase 4 3, Phase 3 21, Phase 2/3 4, Phase 2 32, Phase 1/2 32, Phase 1 46) 2023: 118 trials (Observational 10, Not applicable 7, Phase 3 15, Phase 2/3 4, Phase 2 33, Phase 1/2 22, Phase 1 27) 2024: 123 trials (Observational 11, Not applicable 6, Phase 3 16, Phase 2/3 2, Phase 2 41, Phase 1/2 14, Phase 1 33) 2025: 128 trials (Observational 4, Not applicable 7, Phase 4 2, Phase 3 31, Phase 2/3 3, Phase 2 27, Phase 1/2 23, Phase 1 31)

Trials that list this site and are registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 73
2025 128
2024 123
2023 118
2022 160
2021 184
2020 185
2019 210
2018 187
2017 217

Showing 10 of 37 years.

Start your 14-day trial Email me all 37 years as a PDF

2026 is partial: trials registered with a 2026 start date so far, not a full year. 1 trial is registered to start in 2027 or later, and not listed here

Recent trials

The newest registered trials that list this site. Each title opens its ClinicalTrials.gov record.

Showing 5 of 4,054 trials.

Start your 14-day trial Email me the first 50 trials as a PDF

Source: ClinicalTrials.gov

Lead sponsors

Most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Showing 5 of 490 lead sponsors.

Start your 14-day trial Email me the first 50 lead sponsors as a PDF

Conditions studied

The specific conditions of the trials that list this site, most trials first.

Showing 5 of 480 conditions.

Start your 14-day trial Email me the first 50 conditions as a PDF